Sarcopenia: Prognostic Value for Unresectable Pancreatic Ductal Adenocarcinoma Patients Treated With Gemcitabine Plus Nab-Paclitaxel
Conclusions
Sarcopenia diagnosed by L3-SMI is a prognostic factor in elderly patients who receive GnP for unresectable PDAC. However, GnP exhibits a certain efficacy in sarcopenia and nonsarcopenia patients.
Source: Pancreas - Category: Gastroenterology Tags: Original Articles Source Type: research
More News: Adenocarcinoma | Chemotherapy | CT Scan | Gastroenterology | Pancreas | Pancreatic Cancer | Study